✦ LIBER ✦

Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H)

✍ Scribed by O. Gautschi; N. Blumenthal; M. Streit; M. Solenthaler; T. Hunziker; R. Zenhäusern

Book ID: 114424460
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 191 KB
Volume: 72
Category: Article
ISSN: 0902-4441
DOI: 10.1046/j.0902-4441.2004.00169.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients with advanced myco

Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab

✍ G. A. Kennedy; J. F. Seymour; M. Wolf; H. Januszewicz; J. Davison; C. McCormack; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Successful use of Campath-1H in the trea

Successful use of Campath-1H in the treatment of steroid refractory liver GvHD

✍ Wandroo, F; Auguston, B; Cook, M; Craddock, C; Mahendra, P 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

Successful treatment of refractory metas

Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab

✍ Neerav Shukla; Rachel Kobos; Thomas Renaud; Julie Teruya-Feldstein; Anita Price; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB

Treatment of Severe Refractory Acute Gra

Treatment of Severe Refractory Acute Graft-versus-Host Disease of the Gastrointestinal Tract with Campath-1H

✍ Alessandro Busca; Franco Locatelli; Elisabetta Lovisone; Antonio Ottobrelli; Dan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Treatment of refractory chronic lymphocy

Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infection

✍ Ulrike Heider; Claudia Fleissner; Ivana Zavrski; Christian Jakob; Toralf Dietzel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Treatment of active refractory rheumatoi

Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody campath-1h administered by daily subcutaneous injection

✍ Eric L. Matteson; David E. Yocum; E. William St. Clair; Antonio A. Achkar; Micha 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Objective. To investigate the dose tolerance and potential clinical activity of a humanized antilymphocyte monoclonal antibody, CAMPATH-1H (ClH), in patients with active, refractory rheumatoid arthritis (RA). Methods. Thirty adult patients with active, refractory RA were treated in an open-label, 3